Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkersStéphane Roche, Audrey Gabelle, Sylvain Lehmann
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?Sylvain Lehmann, Audrey Gabelle, Claire Paquet
Psychologie & Neuropsychiatrie Du Vieillissement|May 2, 2013
[Parkinson's disease dementia and Lewy body dementia]Florence Portet, Audrey Gabelle, Jacques Touchon
Clinical Chemistry and Laboratory Medicine|April 15, 2015
Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's diseaseSylvain Lehmann, Constance Delaby, Claire Paquet, et al.
Frontiers in Aging Neuroscience|June 27, 2014
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsyYves A Dauvilliers, Sylvain Lehmann, Isabelle Jaussent, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|December 8, 2011
Can event-related potential predict the progression of mild cognitive impairment?Karim Bennys, Gérard Rondouin, Elise Benattar, et al.
Alzheimer'S Research & Therapy|January 21, 2022
Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderlyClémence Cavaillès, Claudine Berr, Catherine Helmer, et al.
Scientific Reports|May 12, 2016
From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluidChristophe Hirtz, Jérôme Vialaret, Audrey Gabelle, et al.
Frontiers in Neuroscience|June 19, 2018
A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative ReviewIsmael Conejero, Sophie Navucet, Jacques Keller, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial SiderosisDimitri Renard, Audrey Gabelle, Christophe Hirtz, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkersStéphane Roche, Audrey Gabelle, Sylvain Lehmann
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?Sylvain Lehmann, Audrey Gabelle, Claire Paquet
Psychologie & Neuropsychiatrie Du Vieillissement|May 2, 2013
[Parkinson's disease dementia and Lewy body dementia]Florence Portet, Audrey Gabelle, Jacques Touchon
Clinical Chemistry and Laboratory Medicine|April 15, 2015
Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's diseaseSylvain Lehmann, Constance Delaby, Claire Paquet, et al.
Frontiers in Aging Neuroscience|June 27, 2014
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsyYves A Dauvilliers, Sylvain Lehmann, Isabelle Jaussent, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|December 8, 2011
Can event-related potential predict the progression of mild cognitive impairment?Karim Bennys, Gérard Rondouin, Elise Benattar, et al.
Alzheimer'S Research & Therapy|January 21, 2022
Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderlyClémence Cavaillès, Claudine Berr, Catherine Helmer, et al.
Scientific Reports|May 12, 2016
From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluidChristophe Hirtz, Jérôme Vialaret, Audrey Gabelle, et al.
Frontiers in Neuroscience|June 19, 2018
A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative ReviewIsmael Conejero, Sophie Navucet, Jacques Keller, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial SiderosisDimitri Renard, Audrey Gabelle, Christophe Hirtz, et al.
Pageof 18